Log in

NASDAQ:CRVSCorvus Pharmaceuticals News Headlines

$2.01
-0.04 (-1.95 %)
(As of 04/6/2020 06:54 AM ET)
Add
Compare
Today's Range
$1.98
Now: $2.01
$2.17
50-Day Range
$1.74
MA: $3.09
$4.61
52-Week Range
$1.01
Now: $2.01
$8.10
Volume56,884 shs
Average Volume154,493 shs
Market Capitalization$58.95 million
P/E RatioN/A
Dividend YieldN/A
Beta2.04

Headlines

Corvus Pharmaceuticals (NASDAQ CRVS) News Headlines

Source:
DateHeadline
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) Given Consensus Recommendation of "Buy" by AnalystsCorvus Pharmaceuticals Inc (NASDAQ:CRVS) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - April 4 at 3:38 AM
 Brokerages Anticipate Corvus Pharmaceuticals Inc (NASDAQ:CRVS) to Post -$0.40 Earnings Per Share Brokerages Anticipate Corvus Pharmaceuticals Inc (NASDAQ:CRVS) to Post -$0.40 Earnings Per Share
www.americanbankingnews.com - March 22 at 8:14 PM
Corvus Pharma files to offer up to $50M in stockCorvus Pharma files to offer up to $50M in stock
seekingalpha.com - March 20 at 7:08 PM
Corvus Pharmaceuticals (NASDAQ:CRVS) Price Target Lowered to $8.00 at WedbushCorvus Pharmaceuticals (NASDAQ:CRVS) Price Target Lowered to $8.00 at Wedbush
www.americanbankingnews.com - March 13 at 9:15 AM
Edited Transcript of CRVS earnings conference call or presentation 5-Mar-20 9:30pm GMTEdited Transcript of CRVS earnings conference call or presentation 5-Mar-20 9:30pm GMT
finance.yahoo.com - March 10 at 2:25 PM
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2019 Results - Earnings Call TranscriptCorvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 6 at 1:29 AM
Corvus Pharmaceuticals EPS misses by $0.04Corvus Pharmaceuticals EPS misses by $0.04
seekingalpha.com - March 5 at 8:29 PM
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 5 at 8:29 PM
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 5 at 8:29 PM
Corvus Pharmaceuticals, Inc. to Host Earnings CallCorvus Pharmaceuticals, Inc. to Host Earnings Call
www.baystreet.ca - March 5 at 3:01 PM
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter 2019 Financial Results on March 5, 2020Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter 2019 Financial Results on March 5, 2020
finance.yahoo.com - February 28 at 8:09 PM
Richard Miller Awarded 2020 Drug Hunter Award by UC Drug Discovery ConsortiumRichard Miller Awarded 2020 Drug Hunter Award by UC Drug Discovery Consortium
finance.yahoo.com - February 19 at 5:53 PM
Corvus lead drug in prostate cancer fails to excite investors, shares down 14%Corvus lead drug in prostate cancer fails to excite investors, shares down 14%
seekingalpha.com - February 13 at 1:49 PM
Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1b/2 Clinical Trial of Ciforadenant at the 2020 American Society of Clinical Oncology’s Genitourinary Cancers SymposiumCorvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1b/2 Clinical Trial of Ciforadenant at the 2020 American Society of Clinical Oncology’s Genitourinary Cancers Symposium
finance.yahoo.com - February 13 at 8:49 AM
Corvus Pharma up 4% on updated CPI-818 dataCorvus Pharma up 4% on updated CPI-818 data
seekingalpha.com - February 3 at 1:38 PM
Corvus Pharmaceuticals: Turnaround In Progress, Multiple Readouts AheadCorvus Pharmaceuticals: Turnaround In Progress, Multiple Readouts Ahead
seekingalpha.com - January 20 at 5:52 PM
Hedge Funds Aren’t Crazy About Corvus Pharmaceuticals, Inc. (CRVS) AnymoreHedge Funds Aren’t Crazy About Corvus Pharmaceuticals, Inc. (CRVS) Anymore
finance.yahoo.com - December 20 at 11:14 AM
Read This Before Selling Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) SharesRead This Before Selling Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Shares
finance.yahoo.com - December 17 at 8:05 AM
Selective ITK inhibitor was well tolerated with demonstration of specific target occupancySelective ITK inhibitor was well tolerated with demonstration of specific target occupancy
www.globenewswire.com - December 9 at 12:49 PM
Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual MeetingCorvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 7 at 12:09 PM
Corvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingCorvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - November 8 at 8:09 AM
Corvus Pharmaceuticals to Present Preclinical and Early Clinical Data from the Phase 1/1b Trial with CPI-818 at the American Society of Hematology (ASH) Annual MeetingCorvus Pharmaceuticals to Present Preclinical and Early Clinical Data from the Phase 1/1b Trial with CPI-818 at the American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - November 7 at 8:47 AM
Corvus Pharmaceuticals to Present at the 28th Annual Credit Suisse Healthcare ConferenceCorvus Pharmaceuticals to Present at the 28th Annual Credit Suisse Healthcare Conference
finance.yahoo.com - November 5 at 10:30 AM
Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 8, 2019Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 8, 2019
finance.yahoo.com - November 4 at 12:24 PM
Edited Transcript of CRVS earnings conference call or presentation 29-Oct-19 8:30pm GMTEdited Transcript of CRVS earnings conference call or presentation 29-Oct-19 8:30pm GMT
finance.yahoo.com - November 1 at 4:24 AM
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q3 2019 Results - Earnings Call TranscriptCorvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - October 29 at 11:01 PM
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - October 29 at 6:01 PM
CRVS Corvus Pharmaceuticals, Inc. Common StockCRVS Corvus Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - October 26 at 1:42 PM
Companies Like Corvus Pharmaceuticals (NASDAQ:CRVS) Are In A Position To Invest In GrowthCompanies Like Corvus Pharmaceuticals (NASDAQ:CRVS) Are In A Position To Invest In Growth
finance.yahoo.com - October 18 at 1:53 PM
Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2019 Financial Results on October 29, 2019Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2019 Financial Results on October 29, 2019
finance.yahoo.com - October 17 at 12:40 PM
Corvus Pharmaceuticals: Bankruptcy Or BlockbusterCorvus Pharmaceuticals: Bankruptcy Or Blockbuster
seekingalpha.com - October 15 at 6:16 PM
Corvus Pharmaceuticals to Present Updated Data from CPI-006 Clinical Trial at the Society for Immunotherapy of Cancer (SITC) Annual MeetingCorvus Pharmaceuticals to Present Updated Data from CPI-006 Clinical Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - October 3 at 5:15 PM
How Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Can Impact Your Portfolio VolatilityHow Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Can Impact Your Portfolio Volatility
finance.yahoo.com - September 3 at 6:15 PM
Corvus Pharmaceuticals (CRVS) Presents At Wedbush PacGrow Healthcare Conference - SlideshowCorvus Pharmaceuticals (CRVS) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
seekingalpha.com - August 16 at 6:16 PM
Corvus Pharmaceuticals to Present at the 2019 Wedbush Healthcare ConferenceCorvus Pharmaceuticals to Present at the 2019 Wedbush Healthcare Conference
finance.yahoo.com - August 7 at 5:20 PM
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q2 2019 Results - Earnings Call TranscriptCorvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 4 at 5:20 PM
Edited Transcript of CRVS earnings conference call or presentation 1-Aug-19 8:30pm GMTEdited Transcript of CRVS earnings conference call or presentation 1-Aug-19 8:30pm GMT
finance.yahoo.com - August 2 at 6:54 PM
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 1 at 5:56 PM
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2019 Financial Results on August 1, 2019Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2019 Financial Results on August 1, 2019
finance.yahoo.com - July 24 at 6:05 PM
Corvus Pharmaceuticals: Attractive Entry LevelCorvus Pharmaceuticals: Attractive Entry Level
seekingalpha.com - July 23 at 11:28 AM
Corvus Pharmaceuticals: Insider Buying Ahead Of Potential Turnaround In Second Half Of 2019Corvus Pharmaceuticals: Insider Buying Ahead Of Potential Turnaround In Second Half Of 2019
seekingalpha.com - July 4 at 9:41 AM
Need To Know: Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Insiders Have Been Buying SharesNeed To Know: Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Insiders Have Been Buying Shares
finance.yahoo.com - July 3 at 5:21 PM
Corvus Pharmaceuticals Presents Initial CPI-006 Phase 1/1b Clinical Data at 2019 ASCO Annual MeetingCorvus Pharmaceuticals Presents Initial CPI-006 Phase 1/1b Clinical Data at 2019 ASCO Annual Meeting
finance.yahoo.com - June 2 at 4:52 PM
Corvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare ConferenceCorvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 28 at 9:40 AM
Corvus Pharmaceuticals to Present Initial Clinical Data from CPI-006 Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual MeetingCorvus Pharmaceuticals to Present Initial Clinical Data from CPI-006 Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - May 16 at 11:19 AM
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q1 2019 Results - Earnings Call TranscriptCorvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 13 at 9:48 AM
Edited Transcript of CRVS earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of CRVS earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 5:43 PM
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results
www.globenewswire.com - May 9 at 6:11 PM
Corvus Pharmaceuticals: In The SpotlightCorvus Pharmaceuticals: In The Spotlight
seekingalpha.com - May 6 at 6:09 PM
Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2019 Financial Results on May 9, 2019Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2019 Financial Results on May 9, 2019
finance.yahoo.com - May 1 at 6:05 PM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: What is Blockchain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel